Two Sigma Securities’s Vyant Bio VYNT Stock Holding History
Bought
Maintained
Sold
Other funds holding VYNT
Two Sigma Securities's VYNT Position: Q4 2022 in Review
Two Sigma Securities sold out of Vyant Bio (VYNT) in Q4 2022, closing a stake of 4,307 shares — an estimated $12K sold.
Two Sigma Securities first reported a position in VYNT in Q1 2017 and held it in 8 quarters. The position peaked at $125K in Q4 2017. 17 funds tracked by Wall St. Rank hold VYNT as of Q4 2022.
- Two Sigma Securities reported no remaining Vyant Bio position as of Q4 2022 after selling out during the quarter.
- Two Sigma Securities sold 4,307 Vyant Bio shares in Q4 2022, an estimated $12K.
- Two Sigma Securities first reported a position in Vyant Bio in Q1 2017 and held it in 8 quarters.
- Two Sigma Securities's Vyant Bio position peaked at $125K in Q4 2017.
- 17 funds tracked by Wall St. Rank held Vyant Bio as of Q4 2022.
Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.